Erschienen in:
05.06.2021 | Letter to the Editor
Anti-glial fibrillary acidic protein antibodies as a cause of reversible splenial lesion syndrome (RESLES): a case report
verfasst von:
Kundian Guo, Xiaohui Lai, Yue Liu, Dong Zhou, Zhen Hong
Erschienen in:
Neurological Sciences
|
Ausgabe 9/2021
Einloggen, um Zugang zu erhalten
Excerpt
Reversible splenial lesion syndrome (RESLES) is a spectrum of disorders radiologically characterized by reversible lesions mainly involving the splenium of the corpus callosum [
1]. RESLES most commonly occurs in patients with seizures, particularly following antiepileptic drugs withdrawal. RESLES can also cause by infections, high-altitude cerebral edema, hypoglycemia, hyper/hyponatremia, cerebral venous thrombosis, several non-epileptic pharmacological agents, and miscellaneous conditions including anorexia nervosa, malnutrition, vitamin B12 deficiency, Charco–Marie–Tooth disease, systemic lupus erythematosus, and eclampsia [
1‐
3]. Autoimmune encephalitis as a rare condition associated with RESLES was reported in only one anti-NMDAR encephalitis, one anti-VGKC encephalitis, and one anti-Yo encephalitis case, respectively [
3‐
5]. …